Puma Biotechnology, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PBYI research report →
About the company
Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications.
- CEO
- Alan H. Auerbach
- IPO
- 2012
- Employees
- 172
- HQ
- Los Angeles, CA, US
Price Chart
- Market Cap
- $420.43M
- P/E
- 16.65
- P/S
- 1.85
- P/B
- 3.27
- EV/EBITDA
- 8.91
- Div Yield
- 0.00%
- Gross Margin
- 74.46%
- Op Margin
- 12.98%
- Net Margin
- 10.73%
- ROE
- 20.37%
- ROIC
- 17.12%
- Revenue
- $228.37M · -0.91%
- Net Income
- $31.11M · 2.75%
- EPS
- $0.62 · 0.00%
- Op Income
- $37.30M
- FCF YoY
- 7.38%
- 52W High
- $8.41
- 52W Low
- $3.03
- 50D MA
- $7.35
- 200D MA
- $6.28
- Beta
- 1.19
- Avg Volume
- 285.55K
Get TickerSpark's AI analysis on PBYI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | WILSON TROY EDWARD | other | 27,000 |
| Jun 12, 26 | WILSON TROY EDWARD | sell | 10,800 |
| Jun 11, 26 | Stuglik Brian M | other | 27,000 |
| Jun 12, 26 | Stuglik Brian M | sell | 8,100 |
| Jun 11, 26 | Senderowicz Adrian | other | 27,000 |
| Jun 12, 26 | Senderowicz Adrian | sell | 27,000 |
| Jun 11, 26 | MILLER MICHAEL PATRICK | other | 27,000 |
| Jun 11, 26 | MOYES JAY M | other | 27,000 |
| Jun 12, 26 | MOYES JAY M | sell | 22,000 |
| Jun 11, 26 | Dorval Allison | other | 27,000 |
Our PBYI coverage
Recent articles, reports, and earnings notes.
No research on PBYI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PBYI report →Similar companies
Peers in the same neighborhood.